2017 annual financial data
PTC Therapeutics 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was -5.18%.
Operating income was -64,292,000 USD and net income was -79,000,000 USD.
Operating cash flow was -10,063,000 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 194,392,000 USD
- Operating income
- -64,292,000 USD
- Net income
- -79,000,000 USD
- Operating cash flow
- -10,063,000 USD